GlassScriptPhysician profile
Peter A Shaftel
NPI 1447242011
$7,892.91
in general payments reported to CMS, 2019-2025
37 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,444 · 2020: $646 · 2021: $1,546 · 2022: $1,439 · 2023: $1,366 · 2024: $1,103 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,817.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $798.74 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $784.27 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $738.23 | 2019-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Pfizer INC. | $663.04 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $651.08 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $627.67 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $602.63 | 2019-2025 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $483.74 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $423.18 | 2019-2024 | |
| Amarin Pharma, INC. | $288.90 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.90 | 2019-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.59 | 2019-2025 | Jardiance |
| Medtronic, INC. | $149.76 | 2021-2024 | Attain Command + Surevalve, Linq II, Mycarelink |
| Novo Nordisk INC | $133.50 | 2021-2024 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $119.46 | 2021-2024 | Nexletol |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $109.52 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $99.36 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $94.60 | 2019-2020 | |
| Philips North America LLC | $92.21 | 2020-2023 | |
| Portola Pharmaceuticals, LLC | $85.46 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.50 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $77.20 | 2021 | |
| Edwards Lifesciences Corporation | $63.09 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Irhythm Technologies, INC. | $53.21 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $43.98 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $33.86 | 2020-2024 | Optimizer |
| Daiichi Sankyo INC. | $28.60 | 2024 | Injectafer |
| Baxter Healthcare | $23.69 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Braemar Manufacturing, LLC | $22.18 | 2019 | |
| Lundbeck LLC | $21.88 | 2021 | |
| Agepha Pharma Fz LLC | $19.19 | 2024 | Lodoco |
| Scpharmaceuticals INC. | $18.54 | 2023 | |
| Biogen, INC. | $18.02 | 2024 | Skyclarys |
| Kiniksa Pharmaceuticals, LTD. | $17.85 | 2023 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $15.61 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $13.99 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shaftel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.